Pharmaceutical companies traditionally relied on a variety of external suppliers to develop custom drug delivery systems, integrate primary packaging, fabricate automation equipment, and perform manufacturing services. Today, the process can be simplified through organizations which provide a centralized product and service offering that minimizes the risk and burden for pharma partners. A recent project with a leading European pharma company highlights the benefits of this streamlined approach to drug delivery device manufacturing.
The customer needed highly resistant glass cartridges that could be easily integrated with a pen injector used in a range of treatments. Stevanato Group combined its glass expertise with proven testing methods and statistical analysis to establish a viable solution.